메뉴 건너뛰기




Volumn 115, Issue SUPPL. 10, 2009, Pages 2355-2360

Neoadjuvant (presurgical) therapy for renal cell carcinoma: A new treatment paradigm for locally advanced and metastatic disease

Author keywords

Neoadjuvant therapy; Nephrectomy; Renal cell carcinoma; Targeted therapy; Transduction pathways

Indexed keywords

BEVACIZUMAB; SORAFENIB; SUNITINIB;

EID: 65949111709     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24240     Document Type: Conference Paper
Times cited : (60)

References (15)
  • 1
    • 33749446478 scopus 로고    scopus 로고
    • Surgical management of renal cell carcinoma
    • Leibovich BC, Blute ML. Surgical management of renal cell carcinoma. Semin Oncol. 2006;33:552-562.
    • (2006) Semin Oncol , vol.33 , pp. 552-562
    • Leibovich, B.C.1    Blute, M.L.2
  • 2
    • 0042320473 scopus 로고    scopus 로고
    • The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma
    • Wood CG. The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma. Urol Clin North Am. 2003;30:581-588.
    • (2003) Urol Clin North Am , vol.30 , pp. 581-588
    • Wood, C.G.1
  • 3
    • 0035934596 scopus 로고    scopus 로고
    • Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renalcell carcinoma: A randomised trial
    • Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renalcell carcinoma: a randomised trial. Lancet. 2001;358:966-970.
    • (2001) Lancet , vol.358 , pp. 966-970
    • Mickisch, G.H.1    Garin, A.2    Van Poppel, H.3
  • 5
    • 33748569461 scopus 로고    scopus 로고
    • Prognostic factors in metastatic renal cell carcinoma: Metastasectomy as independent prognostic variable
    • Vogl UM, Zehetgruber H, Dominkus M, et al. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable. Br J Cancer. 2006;95:691-698.
    • (2006) Br J Cancer , vol.95 , pp. 691-698
    • Vogl, U.M.1    Zehetgruber, H.2    Dominkus, M.3
  • 6
    • 41449093920 scopus 로고    scopus 로고
    • Adjuvant approaches to renal cell carcinoma
    • Wood CG. Adjuvant approaches to renal cell carcinoma. Clin Adv Hematol Oncol. 2008;6:19-21.
    • (2008) Clin Adv Hematol Oncol , vol.6 , pp. 19-21
    • Wood, C.G.1
  • 7
    • 33846850577 scopus 로고    scopus 로고
    • Adjuvant therapy for high-risk renal cell carcinoma patients
    • Kunkle DA, Haas NB, Uzzo RG. Adjuvant therapy for high-risk renal cell carcinoma patients. Curr Urol Rep. 2007;8:19-30.
    • (2007) Curr Urol Rep , vol.8 , pp. 19-30
    • Kunkle, D.A.1    Haas, N.B.2    Uzzo, R.G.3
  • 8
    • 0030751476 scopus 로고    scopus 로고
    • Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma
    • DOI 10.1016/S0022-5347(01)64091-6
    • Walther MM, Yang JC, Pass HI, et al. Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol. 1997;158:1675-1678. (Pubitemid 27433129)
    • (1997) Journal of Urology , vol.158 , Issue.5 , pp. 1675-1678
    • Walther, M.M.1    Yang, J.C.2    Pass, H.I.3    Linehan, W.M.4    Rosenberg, S.A.5
  • 9
    • 33846519375 scopus 로고    scopus 로고
    • Presurgical therapy in metastatic renal cell carcinoma
    • Jonasch E. Presurgical therapy in metastatic renal cell carcinoma. Expert Rev Anticancer Ther. 2007;7:73-78.
    • (2007) Expert Rev Anticancer Ther , vol.7 , pp. 73-78
    • Jonasch, E.1
  • 10
    • 33846867459 scopus 로고    scopus 로고
    • Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: Combining surgery and systemic therapies to improve patient outcome
    • Wood CG. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res. 2007;13:697s-702s.
    • (2007) Clin Cancer Res , vol.13
    • Wood, C.G.1
  • 11
    • 44649192971 scopus 로고    scopus 로고
    • Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma
    • Margulis V, Matin SF, Tannir N, et al. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol. 2008;180:94-98.
    • (2008) J Urol , vol.180 , pp. 94-98
    • Margulis, V.1    Matin, S.F.2    Tannir, N.3
  • 12
    • 39449121694 scopus 로고    scopus 로고
    • Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi
    • Karakiewicz PI, Suardi N, Jeldres C, et al. Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol. 2008;53:845-848.
    • (2008) Eur Urol , vol.53 , pp. 845-848
    • Karakiewicz, P.I.1    Suardi, N.2    Jeldres, C.3
  • 13
    • 50049092572 scopus 로고    scopus 로고
    • Neoadjuvant targeted therapy and advanced kidney cancer: Observations and implications for a new treatment paradigm
    • Shuch B, Riggs SB, Larochelle JC, et al. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int. 2008;102:692-696.
    • (2008) BJU Int , vol.102 , pp. 692-696
    • Shuch, B.1    Riggs, S.B.2    Larochelle, J.C.3
  • 14
    • 42249091688 scopus 로고    scopus 로고
    • Sunitinib for treatment of advanced renal cell cancer: Primary tumor response
    • van der Veldt AA, Meijerink MR, van den Eertwegh AJ, et al. Sunitinib for treatment of advanced renal cell cancer: primary tumor response. Clin Cancer Res. 2008;14:2431-2436.
    • (2008) Clin Cancer Res , vol.14 , pp. 2431-2436
    • Van Der Veldt, A.A.1    Meijerink, M.R.2    Van Den Eertwegh, A.J.3
  • 15
    • 0032883614 scopus 로고    scopus 로고
    • Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place
    • DOI 10.1097/00005392-199907000-00011
    • Wagner JR, Walther MM, Linehan WM, et al. Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place. J Urol. 1999;162:43-45. (Pubitemid 29420876)
    • (1999) Journal of Urology , vol.162 , Issue.1 , pp. 43-45
    • Wagner, J.R.1    Walther, M.M.2    Linehan, W.M.3    White, D.E.4    Rosenberg, S.A.5    Yang, J.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.